Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Editas Medicine's Cash, Cash Equivalents, And Marketable Securities As Of September 30, 2023, Were $446.4M, Expected To Provide A Cash Runway Into Q3 Of 2025

Author: Benzinga Newsdesk | November 03, 2023 07:04am

Posted In: EDIT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist